Pre- and post-treatment predictors of the early achievement of HBeAg loss in lamivudine-resistant patients receiving adefovir therapy.

MLA

Jeong Won Jang, et al. “Pre- and Post-Treatment Predictors of the Early Achievement of HBeAg Loss in Lamivudine-Resistant Patients Receiving Adefovir Therapy.” Journal of Gastroenterology & Hepatology, vol. 22, no. 7, July 2007, pp. 1092–97. EBSCOhost, https://doi.org/10.1111/j.1440-1746.2006.04499.x.

APA

Jeong Won Jang, Min Soo Kim, So Yeon Lee, Chang Wook Kim, Si Hyun Bae, Jong Young Choi, Sang Bok Cha, & Seung Kew Yoon. (2007). Pre- and post-treatment predictors of the early achievement of HBeAg loss in lamivudine-resistant patients receiving adefovir therapy. Journal of Gastroenterology & Hepatology, 22(7), 1092–1097. https://doi.org/10.1111/j.1440-1746.2006.04499.x

Chicago

Jeong Won Jang, Min Soo Kim, So Yeon Lee, Chang Wook Kim, Si Hyun Bae, Jong Young Choi, Sang Bok Cha, and Seung Kew Yoon. 2007. “Pre- and Post-Treatment Predictors of the Early Achievement of HBeAg Loss in Lamivudine-Resistant Patients Receiving Adefovir Therapy.” Journal of Gastroenterology & Hepatology 22 (7): 1092–97. doi:10.1111/j.1440-1746.2006.04499.x.